-- 据《金融时报》周二援引贸易消息人士报道，中国国有石油巨头计划最早于5月恢复汽油、柴油和航空燃油的出口，此举有望缓解中东冲突持续造成的全球供应紧张局面。 中国最大的炼油企业已申请下个月的出口许可证。此举标志着中国正逐步放弃冲突初期实施的实际出口禁令。该禁令旨在保护地缘政治动荡时期的石油供应。 报道援引Kpler的数据称，在冲突爆发前，中国是亚太地区成品油的主要供应国，日出口量约为80万桶。北京是澳大利亚、日本、越南、菲律宾和孟加拉国等国的主要成品油供应国。 作为全球第二大石油消费国，中国正准备最早于5月恢复出口，预计出口将主要集中在亚洲，因为亚洲的供应短缺问题日益严重。 亚洲受持续能源危机冲击最为严重，该地区炼油厂约80%的供应依赖进口。中东地区约占这些进口量的一半，使得该地区极易受到供应中断的影响。已联系国务院新闻办公室寻求置评。 中国已开始出于人道主义考虑，向部分邻国有限度地出售燃料，凸显了其作为亚洲唯一拥有足够炼油能力大规模出口的经济体的地位。 与此同时，国际贸易机构表示，多家中国国有炼油企业近期获得了新的出口配额，表明海外出口正在全面重启。 尽管在冲突爆发前已建立了创纪录的库存，但中国对大宗商品供应风险仍保持高度谨慎，这凸显了北京方面对市场稳定的持续担忧。 上个月，当局还加强了对某些化肥混合物的管控，进一步强化了针对关键战略大宗商品的供应管理措施。 （市场动态新闻来源于与全球市场专业人士的对话。这些信息据信来自可靠来源，但可能包含传闻和推测。准确性无法保证。）
Related Articles
Research
Research Alert: Equity Residential Delivers Slight Ffo Beat And Revenue Miss In Q1 2026
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:EQR delivered Q1 2026 FFO of $0.99, beating consensus by $0.02, though rental revenue of $780M slightly missed expectations. The company's blended lease rate of 1.5% remained flat Y/Y, with new lease rates declining 2.8% due to incentives offset by strong renewal rates of 4.7%. We maintain our Hold rating based on operating expense pressure suppressing cash NOI growth in 2026. Management guides for 2026 same-store revenue growth of 1.2%-3.2%, expense growth of 3.0%-4.0%, and cash NOI growth of 0.5%-2.5%, with strength expected in 2H 2026. EQR's coastal market strategy continues demonstrating value, with San Francisco leading at 6.5% revenue growth and New York at 4.6%, while expansion markets like Denver (-5.9%) and Atlanta (-2.0%) face new supply pressure. EQR has premium coastal markets where limited new supply enables pricing power, though higher operating costs remain a risk. The development pipeline totals $863M for 1,824 units when complete. Planned property acquisitions are $165M in 2026.
$EQR
Asia
Rua Bioscience Notes 'Significant Contraction' in Australian Medical Cannabis Prescribing Volumes Amid Regulatory Review
Rua Bioscience (NZE:RUA) said the Australian market has experienced "significant contraction" in medical cannabis prescribing volumes amid a Therapeutic Goods Administration review of the safety of unapproved products, according to a Wednesday filing with the New Zealand bourse.However, medicinal cannabis is showing "strong signs of maturity and growth" in international markets, especially in Europe, in the face of recent international developments and discourse of a global economic slowdown, Rua added.The company recently established RUA genetics in Canada, the second-largest cannabis market in the world after the US, adding to its presence in Germany, Australia, New Zealand, Czechia, and the UK, per the filing.In Australia, the company expects a market reset after the regulatory review is complete, and is working to establish its products in new clinic chains.Elsewhere, Rua plans to bring several products to the New Zealand market in the coming months, and is also working on product launches in Czechia scheduled for May. Additionally, the company is looking to expand in the UK with plans to incorporate its genetics through new channels and clinic chains.In Germany, the company believes there is strong demand for consistent and reliable suppliers as significant regulatory changes seem unlikely following a review during which distributors reduced stock and scaled back imports. The German market remains competitive and continues to show strong signs of growth, Rua said.
$NZE:RUA
Treasury
Market Chatter: Nvidia-Linked Data Center Raises $4.6 Billion From Junk Bond Sale
A Nevada data center project tied to Nvidia (NVDA) has raised $4.59 billion through a junk-bond sale, underscoring a rise in deals for AI infrastructure funding, Bloomberg reported on Tuesday, citing a person familiar with the matter.The deal, backed by Tract Capital Management and Fleet Data Centers, priced five-year notes at a 6.74% yield, the report said.The project, a 200-megawatt facility in Nevada, is expected to be leased to Nvidia.The deal was priced during broader volatility in data center-linked stocks and bonds, as concerns grow over whether the rapid expansion in AI-related spending will deliver expected returns, Bloomberg said.Nvidia did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$NVDA